| abstract |
The present invention relates to a new use of phosphatidylserine and of several analogous chemical compounds in various degenerative pathologies, also associated with autoimmune disfunctions wherein the tumor necrosis factor (TNF) is involved. The innovation of the use of the present invention is particularly relevant for the pharmacological therapy of pathologies such as multiple sclerosis (MS) and of other various (physiopathologic) phenomema, wherein the involvement of the above mentioned factor has been ascertained. |